Lifestyle Changes in Fatty Liver; Additive Effect of Honey Intake
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: honey intake and lifestyle changes, lifestyle changes.
- Who it may be relevant to
- Registry conditions: Fatty Liver, Nonalcoholic. Basic parameters: 30 years — 50 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
honey is a natural functional food used in control cardiovascular risk factors but its effect on fatty liver is not investigated
Detailed description
Forty fatty liver (non-alcoholic from) patients with obesity are included to be divided into group 1 who will contain 20 patients who will receive honey intake (orally, as a daily total dose of 2 g/kg, this dose will be divided to three equal subdoses, every dose will be administered before meal), low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks. Group 2 who will contain 20 patients who will receive low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks.
Interventions
- Behavioral honey intake and lifestyle changes
Twenty fatty liver (non-alcoholic from) patients with obesity are included as 20 patients who will receive natural unprocessed honey intake (orally, as a daily total dose of 2 g/kg, this dose will be divided to three equal subdoses, every dose will be administered before meal), low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks. - Behavioral lifestyle changes
Twenty fatty liver (non-alcoholic from) patients with obesity are included as 20 patients who will receive low calorie diet and treadmill walking (40 minutes per session, three times per week) for 12 weeks.
Primary outcome measures
- High density lipoprotein [Time frame: it will be assessed after 12 weeks]
Secondary outcome measures (8)
- triglycerides [Time frame: it will be assessed after 12 weeks]
- cholesterol [Time frame: it will be assessed after 12 weeks]
- low density lipoprotein [Time frame: it will be assessed after 12 weeks]
- alanine transamianse [Time frame: it will be assessed after 12 weeks]
- aspartate transamianse [Time frame: it will be assessed after 12 weeks]
- fasting blood glucose [Time frame: it will be measured after 12 weeks]
- body mass index [Time frame: it will be measured after 12 weeks]
- waist circumference [Time frame: it will be measured after 12 weeks]
Eligibility criteria
Inclusion criteria
- fatty liver (non alcoholic form)
- both sexes included
- obese subjects (class I)
Exclusion criteria
- cardiac insult
- respiratory insult
- renal insult
- lower limb insult
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- faculty of physical therapy Cairo university — Dokki
Identifiers
NCT: NCT06596109 · P.T.REC/012/005163